Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for Redemption of Preference Shares of Caprihans India Limited (Subsidiary), held by the Company

pdf

Bilcare Ltd.

02 Dec 2024

86.51

-2.12%

Corp. Note

BILCARE LTD.-$ - 526853 - Board Meeting Outcome for Disclosure Under Regulation 30 Of SEBI (Listing …

BSE India

Dear Sir, Pursuant to Regulation 30 read with Schedule III, Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at its meeting held on 2nd December, 2024, has approved the subscription to 48,00,000 convertible warrants ("Warrants") issued by Caprihans India Limited ("Subsidiary").

pdf

Bilcare Ltd.

14 Nov 2024

86.51

-2.12%

Company Update

BILCARE LTD.-$ - 526853 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication of Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended 30th September 2024

pdf

Bilcare Ltd.

13 Nov 2024

86.51

-2.12%

Result

BILCARE LTD.-$ - 526853 - Unaudited Financial Results (Standalone And Consolidated) For The Quarter & Half …

BSE India

Enclosed herewith the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended 30th September 2024, along with Limited Review Report of Statutory Auditor thereon.

pdf

Bilcare Ltd.

13 Nov 2024

86.51

-2.12%

Board Meeting

BILCARE LTD.-$ - 526853 - Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results …

BSE India

Unaudited Financial Results (Standalone and Consolidated) for the Quarter & Half year ended 30th September 2024 together with the Limited Review Report of the Statutory Auditor thereon.

pdf

Bilcare Ltd.

06 Nov 2024

86.51

-2.12%

Board Meeting

BILCARE LTD.-$ - 526853 - Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results …

BSE India

BILCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve the Un-Audited Financial Results for the quarter and half year ended September 30, 2024.

pdf